0001179110-21-008665.txt : 20210907
0001179110-21-008665.hdr.sgml : 20210907
20210907174602
ACCESSION NUMBER: 0001179110-21-008665
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210907
FILED AS OF DATE: 20210907
DATE AS OF CHANGE: 20210907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Torley Helen
CENTRAL INDEX KEY: 0001528185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 211240207
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 249 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
edgar.xml
FORM 4 -
X0306
4
2021-09-07
0
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001528185
Torley Helen
C/O HALOZYME THERAPEUTICS, INC.
11388 SORRENTO VALLEY ROAD
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common Stock
2021-09-07
4
M
0
50000
14.66
A
587160
D
Common Stock
2021-09-07
4
S
0
43440
42.286
D
543720
D
Common Stock
2021-09-07
4
S
0
6560
42.979
D
537160
D
Option to Purchase Common Stock
14.66
2021-09-07
4
M
0
50000
14.66
D
2024-01-06
Common Stock
50000
250000
D
The option exercise and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on December 7, 2020, in accordance with Rule 10b5-1.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $41.90 to $42.87. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $42.93 to $43.17. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was January 6, 2014.
/s/ James R. Oehler as attorney-in-fact for Helen Torley
2021-09-07